Chronic Obstructive Pulmonary Diseases:Journal of the COPD Foundation

COVID-19 Article Collection

This page serves as a collection of all Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation (JCOPDF) articles related to coronavirus disease 2019 (COVID-19).

It contains both articles already published in an issue and articles currently in Articles in Press, awaiting publication in the next JCOPDF issue. All articles, including those in Articles in Press, have completed peer review.

These articles, like all JCOPDF articles at all times, are freely accessible (with the JCOPDF maintaining copyright and reprint rights/permissions).

Covid-19 Articles:

Global Attitudes of Health Care Providers About Aerosolized Airway Clearance Therapy in Bronchiectasis Patients During the Coronavirus Disease 2019 Pandemic

Pamela J. McShane, MD1 Julie V. Philley, MD1 Delia A. Prieto, MSEd2 Timothy R. Aksamit, MD3

Author Affiliations

  1. Division of Pulmonary and Critical Care Medicine, the University of Texas Health Science Center at Tyler, Tyler, Texas, United States
  2. National Bronchiectasis Research Registry, COPD Foundation, Washington, DC, United States
  3. Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, United States

Address correspondence to:

Pamela J. McShane, MD
Division of Pulmonary and Critical Care Medicine
The University of Texas Health Science Center at Tyler
11937 US Hwy 271
Tyler, TX 75708
Phone: (847) 226-8410
Email: pamela.mcshane@uthct.edu

Abstract

This article does not contain an abstract.

Citation

Citation: McShane PJ, Philley JV, Prieto DA, Aksamit TR. Global attitudes of health care providers about aerosolized airway clearance therapy in bronchiectasis patients during the coronavirus disease 2019 pandemic. Chronic Obstr Pulm Dis. 2021; 8(3): 319-325. doi: http://dx.doi.org/10.15326/jcopdf.8.3.2021.0214

PDF Download

PDF PDF Version (1501KB)

Patient-Driven Research Agenda: What Needs to be Studied in Those Living with COPD During the Coronavirus Disease 2019 Pandemic

Gretchen McCreary, MA1 Danielle Boyce, MPH1 Mary Ellen Houlihan2 Jean Rommes, PhD2 Carol Rubin, MEd, MS3 Karen Deitemeyer2 William Clark, BS4 Cara B. Pasquale, MPH1 Richard A. Mularski, MD, MSHS, MCR5 Elisha Malanga, BS1 Barbara P. Yawn, MD, MSc, MPH1

Author Affiliations

  1. Research Department, COPD Foundation, Washington, DC, United States
  2. COPD Patient-Powered Research Network Governing Board, COPD Foundation, Washington, DC, United States
  3. Patient investigator for the COPD Foundation, Washington, DC, United States
  4. Community Engagement, COPD Foundation, Washington, DC, United States
  5. Kaiser Permanente Center for Health Research, Portland, Oregon, United States

Address correspondence to:

Barbara P. Yawn, MD, MSc
Email: byawn47@gmail.com

Abstract

This article does not contain an abstract.

Citation

Citation: McCreary G, Boyce D, Houlihan ME, et al. Patient-driven research agenda: what needs to be studied in those living with COPD during the coronavirus disease 2019 pandemic. Chronic Obstr Pulm Dis. 2021; 8(3): 314-318. doi: http://dx.doi.org/10.15326/jcopdf.8.3.2021.0203

PDF Download

PDF PDF Version (1209KB)

Journal Club: The Intersection of Racial/Ethnic Disparities in Coronavirus Disease 2019 and COPD

Ron Balkissoon, MD, MSc, DIH, FRCPC1

Author Affiliations

  1. Denver, Colorado

Address correspondence to:

Ron Balkissoon, MD, MSc, DIH, FRCPC
balkissoonr@njhealth.org

Abstract

This article does not contain an abstract.

Citation

Citation: Balkissoon R. Journal club: the intersection of racial/ethnic disparities in coronavirus disease 2019 and COPD. Chronic Obstr Pulm Dis. 2021; 8(2): 292-302. doi: http://dx.doi.org/10.15326/jcopdf.8.2.2021.0227

PDF Download

PDF PDF Version (254KB)

Impact of Chronic Obstructive Pulmonary Disease and Emphysema on Outcomes of Hospitalized Patients with Coronavirus Disease 2019 Pneumonia

Robert M. Marron, MD1 Matthew Zheng, MD1 Gustavo Fernandez Romero, MD1 Huaqing Zhao, PhD2 Raj Patel, MD3 Ian Leopold, MD3 Ashanth Thomas, MD3 Taylor Standiford, MD3 Maruti Kumaran, MD3 Nicole Patlakh, BS1 Jeffrey Stewart, MD1 Gerard J. Criner, MD1 and the Temple University COVID-19 Research Group

Author Affiliations

  1. Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, United States
  2. Department of Clinical Sciences, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, United States
  3. Department of Radiology, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, United States

Address correspondence to:

Robert M. Marron, MD
Phone: (267) 838-2658
E-mail: robert.marron@tuhs.temple.edu

Abstract

Background: Comorbid disease is a risk factor for severe coronavirus disease 2019 (COVID-19) infection. However, initial rates of chronic obstructive pulmonary disease (COPD) in case series were low and severity of COVID-19 in COPD patients was variable.

Methods: We performed a retrospective study of patients admitted with COVID-19 and evaluated outcomes in those with and without COPD and/or emphysema. Patients were identified as having COPD if they had a diagnosis in the medical record and a history of airflow-obstruction on spirometry, or a history of tobacco use and prescribed long-acting bronchodilator(s). Computed tomography scans were evaluated by radiologists. Propensity matching was performed for age, body mass index (BMI), and serologic data correlated with severity of COVID-19 disease (D-dimer, C-reactive protein, ferritin, fibrinogen, absolute lymphocyte count, lymphocyte percentage, and lactate dehydrogenase).

Results: Of 577 patients admitted with COVID-19, 103 had a diagnosis of COPD and/or emphysema. The COPD/emphysema cohort was older (67 versus 58, p<0.0001) than the other cohort and had a lower BMI. Among unmatched cohorts those with COPD/emphysema had higher rates of intensive care unit (ICU) admission (35% versus 24.9%, p=0.036) and maximal respiratory support requirements, with more frequent invasive mechanical ventilation (21.4% versus 11.8%), but no significant difference in mortality. After propensity-matching there was no difference in ICU admission, maximal respiratory support requirements, or mortality. Univariate and multivariate regression analyses yielded similar results.

Discussion: Our propensity-matched retrospective cohort study suggests that patients hospitalized with COVID-19 who have COPD and/or emphysema may not have worse outcomes than those without these comorbid conditions.

Citation

Citation: Marron RM, Zheng M, Romero GF, et al.Impact of chronic obstructive pulmonary disease and emphysema on outcomes of hospitalized patients with coronavirus 2019 pneumonia. Chronic Obstr Pulm Dis. 2021; 8(2): 255-268. doi: http://dx.doi.org/10.15326/jcopdf.8.2.2020.0200

PDF Download

PDF PDF Version (5897KB)

New Adopters of Telemedicine During the Coronavirus-19 Pandemic in Respondents to an Online Community Survey: The Case for Access to Remote Management Tools for Individuals with Chronic Obstructive Pulmonary Disease

Danielle M. Boyce, MPH1 Byron M. Thomashow, MD1,2 Jamie Sullivan, MPH1 Ruth Tal-Singer, PhD1

Author Affiliations

  1. COPD Foundation, Washington, DC, United States
  2. Columbia University Medical Center, New York, New York, United States

Address correspondence to:

Danielle Boyce, MPH
COPD Foundation
Email: dboyce@copdfoundation.org
Phone: 267-273-8327

Abstract

Objectives: To investigate telemedicine adoption, emergency department avoidance, and related characteristics of patients with chronic obstructive pulmonary disease (COPD) with and without exacerbations since the coronavirus 2019 (COVID-19) pandemic began.

Methods: We conducted the second of a series of online surveys via SurveyMonkey.com of people with COPD between May 1, 2020 and May 31, 2020. Frequency, percentage, and Fisher’s exact test (2-sided) were calculated using SPSS version 26.

Results: More than half of respondents (157, 64%), indicated that they started using telemedicine in 2020. A total of 47% of respondents reported having had at least 1 exacerbation since January 1, 2020. Respondents who had at least 1 exacerbation in 2020 were more likely to start using telemedicine in 2020 than respondents who did not report any exacerbation in 2020 (75.7% versus 54.3%, p < 0.001). Respondents reporting a 2020 exacerbation indicated having a significantly higher avoidance of emergency health care since the pandemic began (27.8%) as compared to those who did not have an exacerbation in 2020 (10.1%), p < 0.001.

Conclusions: In response to social distancing and other COVID-19 precautions, people with COPD are avoiding traditional, in-person health care environments and turning to telemedicine to prevent and manage exacerbations. Further investigation is needed to identify best practices in and barriers to telemedicine in this population.

Citation

Citation: Boyce DM, Thomashow BM, Sullivan J, Tal-Singer R. New adopters of telemedicine during the coronavirus-19 pandemic in respondents to an online community survey: the case for access to remote management tools for individuals with chronic obstructive pulmonary disease. Chronic Obstr Pulm Dis. 2021; 8(2): 213-218. doi: http://dx.doi.org/10.15326/jcopdf.8.2.2020.0181

PDF Download

PDF PDF Version (1844KB)

Journal Club—Severe Acute Respiratory Syndrome Coronavirus-2: Impact on COPD Patients

Ron Balkissoon, MD, MSc, DIH, FRCPC1

Author Affiliations

  1. Denver, Colorado

Address correspondence to:

Ron Balkissoon, MD, MSc, DIH, FRCPC
balkissoonr@njhealth.org

Abstract

This article does not contain an abstract.

Citation

Citation: Balkissoon R. Journal club—Severe acute respiratory syndrome coronavirus-2: impact on COPD patients. Chronic Obstr Pulm Dis. 2020; 7(4): 413-419. doi: http://dx.doi.org/10.15326/jcopdf.7.4.2020.0188

PDF Download

PDF PDF Version (1245KB)

Smoking Cessation Amid the Coronavirus 2019 Pandemic: Making Every Contact Count

Syed Shahzad Hasan, PhD1 Chia Siang Kow, MPharm2 Keivan Ahmadi, PhD3

Author Affiliations

  1. Department of Pharmacy, University of Huddersfield, Huddersfield, United Kingdom and School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia
  2. School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia
  3. Lincoln Medical School, Universities of Nottingham and Lincoln, Lincolnshire, United Kingdom

Address correspondence to:

Chia Siang Kow, MPharm
School of Postgraduate Studies
International Medical University
Kuala Lumpur, Malaysia
Email: chiasiang_93@hotmail.com

Abstract

This article does not contain an abstract.

Citation

Citation: Hasan SS, Kow CS, Ahmadi K. Smoking cessation amid the coronavirus 2019 pandemic: making every contact count. Chronic Obstr Pulm Dis. 2020; 7(4): 300-302. doi: http://dx.doi.org/10.15326/jcopdf.7.4.2020.0171

PDF Download

PDF PDF Version (501KB)

Thoracic Computed Tomography Features of Coronavirus Disease 2019 Patients with Emphysema

Stephanie Tittaferrante, MD1* Rohit Gupta, MD2* Victor Kim, MD2 on behalf of the Temple University COVID-19 Research Group

Author Affiliations

  1. Department of Internal Medicine, Temple University Health System, Philadelphia, Pennsylvania
  2. Department of Thoracic Medicine and Surgery, Temple University Health System, Philadelphia, Pennsylvania

*These authors contributed equally as first authors. A list of individuals in the Temple University COVID-19 Research Group is provided in the online data supplement.

Address correspondence to:

Stephanie Tittaferrante, MD
Department of Internal Medicine and Surgery
Temple University Health System
Philadelphia, Pennsylvania
Email: stephanie.tittaferrante@tuhs.temple.edu

Abstract

This article does not contain an abstract.

Citation

Citation: Tittaferrante S, Gupta R, Kim V, Temple University Research Group. Thoracic computed tomography features of coronavirus disease 2019 patients with emphysema. Chronic Obstr Pulm Dis. 2020; 7(3): 290-296. doi: http://dx.doi.org/10.15326/jcopdf.7.3.2020.0166

PDF Download

PDF PDF Version (5284KB)

The COPD Foundation Coronavirus Disease 2019 International Medical Experts Survey: Results

Ruth Tal-Singer, PhD1 Barbara P. Yawn, MD1,2 Robert Wise, MD3 Byron M. Thomashow, MD1,4 Danielle M. Boyce, MPH1

Author Affiliations

  1. COPD Foundation, Research Department, Washington, DC
  2. University of Minnesota, Family and Community Health, Minneapolis
  3. Pulmonary and Critical Care, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
  4. Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University, New York, New York

Address correspondence to:

Ruth Tal-Singer, PhD
Email: rtalsinger@copdfoundation.org
Phone: 610-570-4876

Abstract

This article does not contain an abstract.

Citation

Citation: Tal-Singer R, Yawn B, Wise B, Thomashow B, Boyce DM. The COPD Foundation Coronavirus Disease 2019 International Medical Experts Survey: results. Chronic Obstr Pulm Dis. 2020; 7(3): 139-146. doi: http://dx.doi.org/10.15326/jcopdf.7.3.2020.0164

PDF Download

PDF PDF Version (2941KB)

Nebulized Treatments and the Possible Risk of Coronavirus Transmission: Where Is the Evidence?

Donald P. Tashkin, MD1 Igor Z. Barjaktarevic, MD, PhD1

Author Affiliations

 

  1. David Geffen School of Medicine, University of California, Los Angeles

Address correspondence to:

Donald P. Tashkin, MD
Email: dtashkin@mednet.ucla.edu

Abstract

This article does not contain an abstract.

Citation

Citation: Tashkin DP, Barjaktarevic IZ. Nebulized treatments and the possible risk of coronoavirus transmission: where is the evidence? Chronic Obstr Pulm Dis. 2020; 7(3): 136-138. doi: http://dx.doi.org/10.15326/jcopdf.7.3.2020.0161

PDF Download

PDF PDF Version (464KB)

Maintaining Emotional Well-Being During the COVID-19 Pandemic: A Resource for Your Patients

Sara Latham, BA1 Jamie Sullivan, MPH1 Stephanie Williams, RRT1 Michelle N. Eakin, PhD2

Author Affiliations

  1. COPD Foundation, Washington, DC
  2. Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland

Address correspondence to:

Michelle N. Eakin, PhD
Johns Hopkins University
5501 Hopkins Bayview Circle Room 4b.74
Baltimore, MD 21224
Email: Meakin1@jhmi.edu

Abstract

This article does not contain an abstract.

Citation

Citation: Latham S, Sullivan J, Williams S, Eakin MN. Maintaining emotional well-being during the COVID-19 pandemic: a resource for your patients. Chronic Obstr Pulm Dis. 2020; 7(2): 76-78. doi: http://dx.doi.org/10.15326/jcopdf.7.2.2020.0150

Keywords

There are no keywords for this article.

PDF Download

PDF PDF Version (467KB)

COPD at the Time of COVID-19: A COPD Foundation Perspective

Ruth Tal-Singer, PhD1 James D. Crapo, MD2,3

Author Affiliations

  1. COPD Foundation, Washington, D.C.
  2. Editor in Chief, Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, COPD Foundation, Washington, DC
  3. Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, Colorado

Address correspondence to:

Ruth Tal-Singer, PhD
Chief Scientific Strategy Officer
COPD Foundation
Email: rtalsinger@copdfoundation.org

Abstract

This article does not contain an abstract.

Citation

Citation: Tal-Singer R, Crapo JD. COPD at the time of COVID-19: a COPD Foundation perspective. Chronic Obstr Pulm Dis. 2020; 7(2): 73-75. doi: http://dx.doi.org/10.15326/jcopdf.7.2.2020.0149

PDF Download

PDF PDF Version (349KB)
Copyright 2021 by COPD Foundation Disclaimer| Privacy|

The COPD Foundation is a nonprofit, tax-exempt charitable organization under Section 501(c)(3) of the Internal Revenue Code.